https://www.fool.com/investing/general/2014/01/24/glaxosmithklines-eperzan-gets-closer-to-launch.aspx
GlaxoSmithKline's Eperzan Gets Closer to Launch | The Motley Fool
Jan 24, 2014 - Glaxo's (GSK) Eperzan is about to face-off against GLP-1 drugs from Novo (NVO), AstraZeneca (AZN), and Lilly LLY).
the motleyglaxosmithklinegetscloserlaunch